Skip to content

Prevalence of Asymptomatic Rupture in SILIMED Breast Implants

Prevalence of Asymptomatic Rupture in SILIMED Breast Implants

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02206282
Enrollment
390
Registered
2014-08-01
Start date
2006-08-31
Completion date
2011-02-28
Last updated
2014-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Implant Rupture

Brief summary

A prospective clinical research is to assess the prevalence of implant rupture and presence of extracapsular gel in an un-referred population of women who have been implanted with the Silimed gel-filled mammary implants with or without any local or systemic systemic symptoms.

Interventions

None listed

Sponsors

Silimed Industria de Implantes Ltda
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Female * Subject implanted with the original Silimed gel-filled implant.

Exclusion criteria

* MR imaging is not possible because of the following: * Metal implant * Battery activated stimulator * Pregnancy * Tattoos * Body weight \>300 pounds * History of metal fragments in the eye * Any other contraindication to MR exam.

Design outcomes

Primary

MeasureTime frameDescription
Magnetic Resonance Image1 year390 Magnetic Resonance Images.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026